185 related articles for article (PubMed ID: 16603870)
1. Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis.
Boyd MA; Burger DM; Phanuphak P; Cooper DA
AIDS; 2006 Apr; 20(7):1083-5. PubMed ID: 16603870
[No Abstract] [Full Text] [Related]
2. DMP 266 and indinavir combination.
AIDS Patient Care STDS; 1997 Aug; 11(4):287-8. PubMed ID: 11361845
[No Abstract] [Full Text] [Related]
3. Ritonavir and indinavir one year later.
TreatmentUpdate; 2001; 12(12):6-7. PubMed ID: 11570094
[No Abstract] [Full Text] [Related]
4. Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapy.
Saah AJ; Haas DW; DiNubile MJ; Chen J; Holder DJ; Rhodes RR; Shivaprakash M; Bakshi KK; Danovich RM; Graham DJ; Condra JH
J Infect Dis; 2003 Apr; 187(7):1157-62. PubMed ID: 12660932
[TBL] [Abstract][Full Text] [Related]
5. Update on antivirals.
Proj Inf Perspect; 1997 Nov; (23):8-11. PubMed ID: 11365381
[TBL] [Abstract][Full Text] [Related]
6. Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96-week outcomes of HIV-NAT 009.
Boyd MA; Siangphoe U; Ruxrungtham K; Duncombe CJ; Stek M; Lange JM; Cooper DA; Phanuphak P
HIV Med; 2005 Nov; 6(6):410-20. PubMed ID: 16268823
[TBL] [Abstract][Full Text] [Related]
7. An immunological comparison of third companion in advanced drug-naive HIV-infected patients.
Rizzardini G; Trabattoni D; Capetti A; Castelletti E; Migliorino M; Panebianco R; Pacei M; Quirino T; Clerici M
HIV Clin Trials; 2006; 7(5):221-8. PubMed ID: 17162315
[TBL] [Abstract][Full Text] [Related]
8. Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination.
Lallemand F; Adda N; Schneider V; Jacomet C; Salhi Y; Rozenbaum W
Clin Infect Dis; 1999 May; 28(5):1184-5. PubMed ID: 10452672
[No Abstract] [Full Text] [Related]
9. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM
N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Boonyaprawit P
Antivir Ther; 2005; 10(8):911-6. PubMed ID: 16430196
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for ritonavir intolerance and outcome after change to indinavir.
Casado JL; Perez-Elías MJ; Antela A; Martí-Belda P; de Lucas S; Muñoz V; Guerrero A
AIDS; 1998 Feb; 12(3):335-6. PubMed ID: 9580044
[No Abstract] [Full Text] [Related]
12. [HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
Allerg Immunol (Paris); 1998 Apr; 30(4):123-4. PubMed ID: 9631694
[No Abstract] [Full Text] [Related]
13. Efavirenz in HIV infection.
Casado JL; Moreno S
N Engl J Med; 2000 Apr; 342(17):1290-1. PubMed ID: 10787332
[No Abstract] [Full Text] [Related]
14. New study shows efavirenz effective with d4T and 3TC.
AIDS Alert; 1999 May; 14(5):60. PubMed ID: 11366404
[TBL] [Abstract][Full Text] [Related]
15. Using ritonavir with indinavir in cases of virologic failure.
TreatmentUpdate; 2001; 12(12):7. PubMed ID: 11570095
[No Abstract] [Full Text] [Related]
16. [HIV protease inhibitors. A new drug class in antiretroviral therapy].
Mauss S; Seidlitz B; Jablonowski H; Häussinger D
Dtsch Med Wochenschr; 1996 Nov; 121(44):1369-74. PubMed ID: 8964223
[No Abstract] [Full Text] [Related]
17. Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-controlled trial.
Haas DW; Fessel WJ; Delapenha RA; Kessler H; Seekins D; Kaplan M; Ruiz NM; Ploughman LM; Labriola DF; Manion DJ
J Infect Dis; 2001 Feb; 183(3):392-400. PubMed ID: 11133370
[TBL] [Abstract][Full Text] [Related]
18. Influence of indinavir and ritonavir on warfarin anticoagulant activity.
Gatti G; Alessandrini A; Camera M; Di Biagio A; Bassetti M; Rizzo F
AIDS; 1998 May; 12(7):825-6. PubMed ID: 9619821
[No Abstract] [Full Text] [Related]
19. Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
Neukam K; Mira JA; Ruiz-Morales J; Rivero A; Collado A; Torres-Cornejo A; Merino D; de Los Santos-Gil I; Macías J; González-Serrano M; Camacho A; Parra-García G; Pineda JA;
J Antimicrob Chemother; 2011 Nov; 66(11):2605-14. PubMed ID: 21903660
[TBL] [Abstract][Full Text] [Related]
20. Don't mix Sustiva with Fortovase.
Posit Aware; 1998; 9(5):17. PubMed ID: 11365885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
